PHARMACIES WILL BILL $ 10 BI

The modernisation of one third of the drugs sold in the country could increase by as much as $ 10 billion pharmaceutical industry revenues, according to a survey of the Alanac (Association of pharmaceutical laboratories). It would take $ 3 billion in investments to double the market potential of 230 active principles, which today accounts for $ 10 billion, according to a study. "The lack of proper legislation discourages industry because price the product inappropriately, without considering investments in innovation, says Henry Tada, Chief Executive of the entity.